Substance / Medication

Hydrocortisone butyrate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

88 trials linked to this intervention

88
Total Trials
34
Recruiting
15
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Anal Albendazole application for pruritus ani in threadworm infestation.
Singh Shivaram Prasad, Panda Chittaranjan, Rout Niranjan et al. · J Trop Pediatr · 2005
PMID: 15958409RCT
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
Matheson Robert, Kempers Steven, Breneman Debra et al. · J Drugs Dermatol · 2008
PMID: 18380208Observational
[Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
Korting Hans Christian, Maslen Kirstin, Gross Gabi et al. · J Dtsch Dermatol Ges · 2005
PMID: 16372801Observational
Results of patch testing with hydrocortisone butyrate in different vehicles.
Wilkinson S M, Beck M H, Steel I · Contact Dermatitis · 2000
PMID: 10789860Observational
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang Xiaoyan, Trinh Hoang M, Agrahari Vibhuti et al. · AAPS PharmSciTech · 2016
PMID: 26085051OtherFull text (PMC)
Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
Yang Xiaoyan, Patel Sulabh, Sheng Ye et al. · AAPS PharmSciTech · 2014
PMID: 24504495OtherFull text (PMC)
Tacrolimus ointment compared with hydrocortisone acetate in children, and hydrocortisone butyrate in adults.
Beltrani Vincent S · Curr Allergy Asthma Rep · 2002
PMID: 12044259Other
Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis.
Fowler Joseph F, Fransway Anthony F, Jackson J Mark et al. · Cutis · 2005
PMID: 15773535Trial
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
Reitamo Sakari, Rustin Malcolm, Ruzicka Thomas et al. · J Allergy Clin Immunol · 2002
PMID: 11898005Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Hydrocortisone butyrate (substance)
SNOMED CT
50665003
UMLS CUI
C0352536

Clinical Data

This intervention maps to 21 entities in the Ltrl knowledge graph.

11
Conditions
4
Biomarkers
4
Specialists
0
Symptoms
88
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.